Skip to main content

Table 2 Clinical characteristics of included patients

From: Health-related quality of life in Chinese population with non-alcoholic fatty liver disease: a national multicenter survey

Clinical characteristics

Patients (n = 5181)

BMI (kg/m2), Mean ± SD

27.7 ± 6.0

BMI group (n, %)

 

 < 24 kg/m2

978 (18.9)

 24–28 kg/m2

2363 (45.6)

 ≥ 28 kg/m2

1840 (35.5)

Central Obesity (n, %)

3720 (71.8)

Duration of NAFLD (mo), Mean ± SD

36.8 ± 46.5

Disease severity (n, %)

 

 Simple fatty liver

4661 (90.0)

 NASH

187 (3.6)

 Cirrhosis

28 (0.5)

 Unknown

305 (5.9)

Complications (n, %)

 

 Diabetes

801 (15.5)

 Hypertension

1191 (23.0)

 Hyperlipidemia

1955 (37.7)

 Cardiovascular disease

414 (8.0)

 Depression

135 (2.6)

 Colon disease

115 (2.2)

Duration of ongoing treatment (mo), Mean ± SD

12.9 ± 25.9

Laboratory examination, Mean ± SD

 

 ALT (U/L)

53.2 ± 47.0

 TG (mmol/L)

2.4 ± 2.1

  1. NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; BMI, body mass index; SD, standard deviations; mo, months; ALT, alanine transaminase; TG, triglyceride